{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:35:19Z","timestamp":1793313319936,"version":"4.5.0"},"reference-count":79,"publisher":"SAGE Publications","issue":"1-2","license":[{"start":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T00:00:00Z","timestamp":1644969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Anaesth Intensive Care"],"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:p>Opioids are integral to multimodal analgesic regimens in children with moderate to severe acute pain. Throughout normal childhood there are marked changes in physiology, and social and psychological development that influence the perception and expression of pain, the pharmacology of opioids, and how they are used. A multidimensional pain assessment is key to guiding appropriate opioid prescribing. Most of the commonly used opioids in adults are used in children, with the increasing exception of codeine (as a result of regulatory change), and are generally well tolerated. Patient groups at increased risk of ventilatory impairment include neonates and those with obstructive sleep apnoea, severe neurodevelopmental conditions, trisomy 21, and severe epilepsy. Slow-release opioids are not recommended for general use, but may be used in select populations, for example, following scoliosis surgery, major trauma or burns. Prescribing and administration errors are a major issue in paediatrics generally; the potential consequences of opioid prescribing or administration errors are serious, particularly following hospital discharge. Opioids prescribed at discharge are frequently in excess of a child\u2019s analgesic requirements; three to five days supply appears sufficient for the majority of common paediatric operations. Discharge opioid prescriptions have been linked to long-term opioid use in adolescents with risk factors. Misuse of prescription opioids by adolescents is also concerning, with prevalence estimates ranging from 1.1% to 20%. Caregivers have a tendency to underdose opioids in their children; caregiver education may improve appropriate administration. Caregivers must also be provided with instructions on safe storage and disposal of unused opioids.<\/jats:p>","DOI":"10.1177\/0310057x211065769","type":"journal-article","created":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T02:17:14Z","timestamp":1645064234000},"page":"81-94","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":27,"title":["Opioids for acute pain management in children"],"prefix":"10.1177","volume":"50","author":[{"given":"Derek M","family":"Rosen","sequence":"first","affiliation":[{"name":"Department of Anaesthesia and Pain Management, Queensland Children\u2019s Hospital, Brisbane, Queensland, Australia"},{"name":"University of Queensland, Queensland, Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7740-1601","authenticated-orcid":false,"given":"Mark M","family":"Alcock","sequence":"additional","affiliation":[{"name":"Department of Anaesthesia and Pain Management, Queensland Children\u2019s Hospital, Brisbane, Queensland, Australia"},{"name":"University of Queensland, Queensland, Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greta M","family":"Palmer","sequence":"additional","affiliation":[{"name":"Department of Anaesthesia and Pain Management, Royal Children\u2019s Hospital, Melbourne, Victoria, Australia"},{"name":"University of Melbourne, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2022,2,16]]},"reference":[{"key":"bibr1-0310057X211065769","unstructured":"Unicef.\n                      Convention on the Rights of the Child\n                      . https:\/\/www.unicef.org\/child-rights-convention\/convention-text (1989, accessed 20 February 2021)."},{"key":"bibr2-0310057X211065769","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2018-1623"},{"key":"bibr3-0310057X211065769","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2018.6558"},{"key":"bibr4-0310057X211065769","unstructured":"US Department of Health and Human Services.\n                      HHS Acting Secretary Declares Public Health Emergency to Address National Opioid Crisis\n                      . https:\/\/public3.pagefreezer.com\/browse\/HHS.gov\/31-12-2020T08:51\/https:\/\/www.hhs.gov\/about\/news\/2017\/10\/26\/hhs-acting-secretary-declares-public-health-emergency-address-national-opioid-crisis.html (2017, accessed 20 February 2021)."},{"key":"bibr5-0310057X211065769","doi-asserted-by":"publisher","DOI":"10.1097\/00004703-198612000-00004"},{"key":"bibr6-0310057X211065769","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.313.7060.787"},{"key":"bibr7-0310057X211065769","first-page":"885","volume-title":"Acute Pain Management: Scientific Evidence","author":"De Lima J.","year":"2020","edition":"5"},{"key":"bibr8-0310057X211065769","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2013-303720"},{"key":"bibr9-0310057X211065769","doi-asserted-by":"publisher","DOI":"10.18773\/austprescr.2016.071"},{"key":"bibr10-0310057X211065769","doi-asserted-by":"publisher","DOI":"10.1213\/00000539-199702000-00013"},{"key":"bibr11-0310057X211065769","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9592.2009.03242.x"},{"key":"bibr12-0310057X211065769","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9592.2007.02213.x"},{"key":"bibr13-0310057X211065769","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9592.2009.03187.x"},{"key":"bibr14-0310057X211065769","doi-asserted-by":"publisher","DOI":"10.1111\/pan.13639"},{"key":"bibr15-0310057X211065769","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9592.2012.03838.x"},{"key":"bibr16-0310057X211065769","unstructured":"Peck TE, Hill SA, Williams M. Analgesics. In: Pharmacology for Anaesthesia and Intensive care, 2nd ed.  Cambridge:  Cambridge University Press, 2004, ch. 10."},{"key":"bibr17-0310057X211065769","doi-asserted-by":"publisher","DOI":"10.1111\/papr.12345"},{"key":"bibr18-0310057X211065769","unstructured":"Therapeutic Goods Administration.\n                      Australian Product Information \u2013 MS Contin\u00ae (Mundipharma)\n                      . https:\/\/www.ebs.tga.gov.au\/ebs\/picmi\/picmirepository.nsf\/pdf?OpenAgent&id=CP-2010-PI-06782-3&d=202102211016933 (2020, accessed 19 November 2021)."},{"key":"bibr19-0310057X211065769","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-017-0609-2"},{"key":"bibr20-0310057X211065769","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-018-00731-3"},{"key":"bibr21-0310057X211065769","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2013.02.001"},{"key":"bibr22-0310057X211065769","unstructured":"Faculty of Pain Medicine, Australian and New Zealand College of Anaesthetists.\n                      Opioid dose equivalence table\n                      . https:\/\/www.anzca.edu.au\/getattachment\/6892fb13-47fc-446b-a7a2-11cdfe1c9902\/PM01-(Appendix-2)-Opioid-Dose-Equivalence-Calculation-of-Oral-Morphine-Equivalent-Daily-Dose-(oMEDD).aspx (2019, accessed 20 February 2021)."},{"key":"bibr23-0310057X211065769","unstructured":"The Royal Children's Hospital Melbourne.\n                      Patient controlled analgesia guideline\n                      . https:\/\/www.rch.org.au\/anaes\/pain_management\/Patient_Controlled_Analgesia_PCA\/ (accessed 19 November 2021)."},{"key":"bibr24-0310057X211065769","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-199307000-00012"},{"key":"bibr25-0310057X211065769","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2009-0489"},{"key":"bibr26-0310057X211065769","doi-asserted-by":"publisher","DOI":"10.1097\/PCC.0b013e318253c80e"},{"key":"bibr27-0310057X211065769","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003447"},{"key":"bibr28-0310057X211065769","unstructured":"Therapeutic Goods Administration.\n                      Australian Product Information \u2013 Dilaudid\u00ae (Mundipharma)\n                      . https:\/\/www.ebs.tga.gov.au\/ebs\/picmi\/picmirepository.nsf\/pdf?OpenAgent&id=CP-2017-PI-01353-1&d=202102251016933 (2020, accessed 19 November 2021)."},{"key":"bibr29-0310057X211065769","first-page":"929","volume-title":"Acute Pain Management: Scientific Evidence, 5th ed","author":"Burgoyne L","year":"2020"},{"key":"bibr30-0310057X211065769","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2013.254"},{"key":"bibr31-0310057X211065769","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc0904266"},{"key":"bibr32-0310057X211065769","first-page":"33","volume":"53","author":"Madadi P","year":"2007","journal-title":"Can Fam Physician"},{"key":"bibr33-0310057X211065769","unstructured":"Therapeutic Goods Administration.\n                      Safety review: Codeine use in children and ultra-rapid metabolisers\n                      . https:\/\/www.tga.gov.au\/alert\/safety-review-codeine-use-children-and-ultra-rapid-metabolisers (2017, accessed 19 November 2021)."},{"key":"bibr34-0310057X211065769","unstructured":"European Medicines Agency.\n                      Restrictions on use of codeine for pain relief in children \u2013 CMDh endorses PRAC recommendation\n                      . https:\/\/www.ema.europa.eu\/en\/news\/restrictions-use-codeine-pain-relief-children-cmdh-endorses-prac-recommendation (2013, accessed 19 November 2021)."},{"key":"bibr35-0310057X211065769","unstructured":"European Medicines Agency.\n                      Codeine not to be used in children below 12 years for cough and cold\n                      . https:\/\/www.ema.europa.eu\/en\/news\/codeine-not-be-used-children-below-12-years-cough-cold (2015, accessed 19 November 2021)."},{"key":"bibr36-0310057X211065769","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(96)90211-8"},{"key":"bibr37-0310057X211065769","volume-title":"WHO guidelines on the pharmacological treatment of persisting pain in children with medical illnesses","author":"Guidelines Review Committee.","year":"2012"},{"key":"bibr38-0310057X211065769","doi-asserted-by":"publisher","DOI":"10.1111\/pan.13272"},{"key":"bibr39-0310057X211065769","unstructured":"US Federal Drug Adminstration, Drug Safety Communication. FDA restricts use of prescription codeine pain and cough medicines and tramadol pain medicines in children; recommends against use in breastfeeding women FDA Drug Safety Communication. https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-fda-restricts-use-prescription-codeine-pain-and-cough-medicines-and#:\u223c:text=used%20for%20pain (2017, accessed 21 November 2021)."},{"key":"bibr40-0310057X211065769","unstructured":"Society of Paediatric Anaesthetists of New Zealand and Australia.\n                      Advisory on Tramadol \u2013 Recommendations Following FDA Warnings about Tramadol Use\n                      in\n                      Children\n                      . https:\/\/d311i5pe49swog.cloudfront.net\/web-assets\/spanza\/assets\/uploads\/2018\/06\/05163332\/17_05_SPANZA-Advisory-on-Tramadol-31-May-2017.pdf (accessed 21 November 2021)."},{"key":"bibr41-0310057X211065769","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.clinthera.2009.02.009","volume":"31","author":"Hartrick C","year":"2009","journal-title":"Clin Ther"},{"key":"bibr42-0310057X211065769","doi-asserted-by":"publisher","DOI":"10.2165\/11589080-000000000-00000"},{"key":"bibr43-0310057X211065769","doi-asserted-by":"publisher","DOI":"10.2147\/JPR.S197348"},{"key":"bibr44-0310057X211065769","doi-asserted-by":"publisher","DOI":"10.2147\/JPR.S197039"},{"key":"bibr45-0310057X211065769","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2014-2096"},{"key":"bibr46-0310057X211065769","doi-asserted-by":"publisher","DOI":"10.1177\/0269216311406577"},{"key":"bibr47-0310057X211065769","unstructured":"Schug SA, Palmer GM, Scott DA, et\u00a0al. (eds). Analgesic medicines. In:\n                      Acute Pain Management: Scientific Evidence\n                      , 5th ed. Melbourne: ANZCA & FPM, 2020, pp. 106\u2013285."},{"key":"bibr48-0310057X211065769","doi-asserted-by":"publisher","DOI":"10.1093\/bjaed\/mkw049"},{"key":"bibr49-0310057X211065769","unstructured":"Schug SA, Palmer GM, Scott DA, et\u00a0al. (eds). Specific clinical situations. In:\n                      Acute Pain Management: Scientific Evidence\n                      , 5th ed. Melbourne: ANZCA & FPM, 2020, pp. 474\u2013707."},{"key":"bibr50-0310057X211065769","unstructured":"Australian and New Zealand College of Anaesthetists.\n                      Position statement on the use of slow-release opioid preparations in the treatment of acute pain.\n                      https:\/\/www.anzca.edu.au\/getattachment\/d9e2a7c5-0f17-42d3-bda7-c6dae7e55ced\/Position-statement-on-the-use-of-slow-release-opioid-preparations-in-the-treatment-of-acute-pain#:\u223c:text=Slow%2Drelease%20opioids%20are%20not,severe%20adverse%20events%20and%20deaths (2018, accessed 19 November 2021)."},{"key":"bibr51-0310057X211065769","unstructured":"Schug SA (ed). Administration of analgesic medicines. In: Schug SA, Palmer GM, Scott DA, et\u00a0al. (eds)\n                      Acute Pain Management: Scientific Evidence\n                      , 5th ed. Melbourne: ANZCA & FPM, 2020, pp. 286\u2013401."},{"key":"bibr52-0310057X211065769","doi-asserted-by":"publisher","DOI":"10.3945\/ajcn.2010.29786"},{"key":"bibr53-0310057X211065769","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.07.043497"},{"key":"bibr54-0310057X211065769","doi-asserted-by":"publisher","DOI":"10.5863\/1551-6776-15.2.94"},{"key":"bibr55-0310057X211065769","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinane.2017.12.016"},{"key":"bibr56-0310057X211065769","doi-asserted-by":"publisher","DOI":"10.1111\/anae.12860"},{"key":"bibr57-0310057X211065769","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000002664"},{"key":"bibr58-0310057X211065769","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-200610000-00004"},{"key":"bibr59-0310057X211065769","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.6700"},{"key":"bibr60-0310057X211065769","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-200404000-00009"},{"key":"bibr61-0310057X211065769","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-200610000-00009"},{"key":"bibr62-0310057X211065769","volume-title":"Acute Pain Management: Scientific Evidence","author":"Halliwell R","year":"2020"},{"key":"bibr63-0310057X211065769","first-page":"28","volume":"100","author":"American Academy of Pain Medicine, the American Pain Society and the American Society of Addiction Medicine","year":"2001","journal-title":"WMJ"},{"key":"bibr64-0310057X211065769","doi-asserted-by":"publisher","DOI":"10.1097\/PCC.0000000000000306"},{"key":"bibr65-0310057X211065769","first-page":"440","volume":"36","author":"Singleton A","year":"2015","journal-title":"J Burn Care Res"},{"key":"bibr66-0310057X211065769","doi-asserted-by":"publisher","DOI":"10.1002\/phar.2026"},{"key":"bibr67-0310057X211065769","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2013-3398"},{"key":"bibr68-0310057X211065769","doi-asserted-by":"publisher","DOI":"10.1177\/0009922815586050"},{"key":"bibr69-0310057X211065769","unstructured":"Therapeutic Goods Administration.\n                      Australian Product Information \u2013 Oxynorm (Mundipharma)\n                      . https:\/\/www.ebs.tga.gov.au\/ebs\/picmi\/picmirepository.nsf\/pdf?OpenAgent&id=CP-2012-PI-01954-3 (2020, accessed 19 November 2021)."},{"key":"bibr70-0310057X211065769","unstructured":"Therapeutic Goods Administration.\n                      Australian Product Information \u2013 Ordine (Mundipharma)\n                      . https:\/\/www.ebs.tga.gov.au\/ebs\/picmi\/picmirepository.nsf\/pdf?OpenAgent&id=CP-2010-PI-06783-3 (2020, accessed 19 November 2021)."},{"key":"bibr71-0310057X211065769","doi-asserted-by":"publisher","DOI":"10.1016\/j.jss.2013.05.038"},{"key":"bibr72-0310057X211065769","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2015.05.495"},{"key":"bibr73-0310057X211065769","doi-asserted-by":"publisher","DOI":"10.1111\/pan.13659"},{"key":"bibr74-0310057X211065769","unstructured":"The Michigan Opioid Prescribing Engagement Network (OPEN).\n                      Prescribing Recommendations 2020.\n                      https:\/\/michigan-open.org\/prescribing-recommendations\/ (2020, accessed 19 November 2021)."},{"key":"bibr75-0310057X211065769","unstructured":"Australian Institute of Health and Welfare.\n                      Alcohol, tobacco & other drugs in Australia\n                      . https:\/\/www.aihw.gov.au\/reports\/alcohol\/alcohol-tobacco-other-drugs-australia\/contents\/introduction (accessed 19 November 2021)."},{"key":"bibr76-0310057X211065769","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2016-2387"},{"key":"bibr77-0310057X211065769","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2015-1364"},{"key":"bibr78-0310057X211065769","doi-asserted-by":"publisher","DOI":"10.1097\/ACO.0000000000000227"},{"key":"bibr79-0310057X211065769","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2017.11.005"}],"container-title":["Anaesthesia and Intensive Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0310057X211065769","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/0310057X211065769","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0310057X211065769","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T09:12:15Z","timestamp":1777367535000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/0310057X211065769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,16]]},"references-count":79,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["10.1177\/0310057X211065769"],"URL":"https:\/\/doi.org\/10.1177\/0310057x211065769","relation":{},"ISSN":["0310-057X","1448-0271"],"issn-type":[{"value":"0310-057X","type":"print"},{"value":"1448-0271","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,16]]}}}